Berlin - Delayed Quote EUR

Clearmind Medicine Inc (CWY0.BE)

Compare
1.4740
+0.0040
+(0.27%)
As of 7:31:07 PM GMT+1. Market Open.
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for CWY0.BE

Recent News: CWY0.BE

View More
Clearmind Medicine Announces Shareholders Meeting Results

Clearmind Medicine Announces Shareholders Meeting Results
GlobeNewswire 6 days ago
Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment
GlobeNewswire 7 days ago
SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment
GlobeNewswire 7 days ago
Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office
GlobeNewswire 11 days ago
Clearmind Medicine to move forward with MEAI-based alcohol substitute

Clearmind Medicine to move forward with MEAI-based alcohol substitute
TipRanks 17 days ago
Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute
GlobeNewswire 18 days ago
Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial

Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial
GlobeNewswire 20 days ago
Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format

Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format
GlobeNewswire 28 days ago
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site
GlobeNewswire 3 months ago
Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy
GlobeNewswire 3 months ago
Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment

Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment
GlobeNewswire 3 months ago
View More

Related Tickers

1K0.BE IGM Biosciences Inc. R
1.8100
-69.83%
 
LSRM.MU CEL-SCI Corp
0.3962
+9.21%
 
LSRM.SG CEL-SCI Corp
0.4082
+2.25%
 
1K0.F IGM Biosciences, Inc.
1.9400
+2.11%
 
LSRM.F CEL-SCI Corporation
0.3978
+14.38%
 
LSRM.DU CEL-SCI Corp
0.3870
+0.62%
 
LSRM.BE CEL-SCI Corp
0.4082
+17.64%
 
1K0.MU IGM Biosciences Inc
2.1000
-56.25%
 
NFX.L Nuformix plc
0.0475
-20.83%
 
OBD.L Oxford BioDynamics Plc
0.9000
-1.21%